Y.D. More Investments LTD Protalix Bio Therapeutics, Inc. Transaction History
Y.D. More Investments LTD
- $955 Billion
- Q3 2024
A detailed history of Y.D. More Investments LTD transactions in Protalix Bio Therapeutics, Inc. stock. As of the latest transaction made, Y.D. More Investments LTD holds 220 shares of PLX stock, worth $259. This represents 0.0% of its overall portfolio holdings.
Number of Shares
220
Previous 220
-0.0%
Holding current value
$259
Previous $257,000
12.84%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding PLX
# of Institutions
64Shares Held
5.83MCall Options Held
103KPut Options Held
4.6K-
Israel Englander Millennium Management LLC | New York, Ny811KShares$957,1680.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny805KShares$949,4280.0% of portfolio
-
Goldman Sachs Group Inc New York, NY462KShares$545,1100.0% of portfolio
-
Gsa Capital Partners LLP London, X0435KShares$513,5510.03% of portfolio
-
Northern Trust Corp Chicago, IL423KShares$499,3910.0% of portfolio
About Protalix BioTherapeutics, Inc.
- Ticker PLX
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 49,753,400
- Market Cap $58.7M
- Description
- Protalix BioTherapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of recombinant therapeutic proteins based on its proprietary ProCellEx plant cell-based protein expression system in the United States, Australia, Canada, Israel, Brazil, Russia, Turkey, and internationally. The company offers Elelyso fo...